— Know what they know.
Not Investment Advice

000989.SZ SHZ

Jiuzhitang Co., Ltd.
1W: -0.9% 1M: -1.7% 3M: +6.8% YTD: -4.7% 1Y: -24.7% 3Y: -22.3% 5Y: +20.2%
¥8.75 ($1.30)
+0.20 (+2.34%)
 
SHZ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 39 · ¥7.4B mcap · 639M float · 3.94% daily turnover

Cash Flow Trends

Operating Cash Flow
$438M +120.3% ▲
5Y CAGR: -6.4%
Capital Expenditures
$40M +44.7% ▲
5Y CAGR: -13.2%
Free Cash Flow
$398M +214.3% ▲
5Y CAGR: -5.5%
Dividends Paid
$254M +25.0% ▲
Buybacks
$0 +100.0% ▲
Net Change in Cash
-$187M -133.8% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$268M$356M$296M$215M$223M
Depreciation & Amort.$163M$148M$127M$121M$126M
Stock-Based Comp.$36M$14M$0$0$0
Change in Working Capital-$176M$147M-$295M-$95M$80M
Other Non-Cash Items$89M-$173M$6M-$41M$17M
Operating Cash Flow$366M$499M$121M$199M$438M
— Investing Activities —
Capital Expenditures-$207M-$97M-$73M-$72M-$40M
Acquisitions (Net)$440K$184M$0$0-$164M
Investment Purchases-$4.0B-$2.6B-$2.6B-$1.5B-$4.2B
Investment Sales$4.2B$2.6B$2.4B$1.6B$4.0B
Other Investing$72K$331K-$12M$55M$0
Investing Cash Flow$63M$84M-$302M$94M-$474M
— Financing Activities —
Net Debt Issuance-$102M-$24M-$9M-$2M$57M
Stock Repurchased-$80M$0$0-$76M$0
Dividends Paid-$342M-$342M-$342M-$339M-$254M
Other Financing$29M$64M$115M$44M-$16M
Financing Cash Flow-$415M-$303M-$236M-$373M-$214M
Net Change in Cash$13M$281M-$417M-$80M-$187M
Cash End of Period$808M$1.1B$673M$593M$406M
Free Cash Flow$159M$402M$36M$127M$398M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms